BAYESIAN APPROACH TO NONINFERIORITY TRIALS FOR PROPORTIONS

被引:22
作者
Gamalo, Mark A. [1 ]
Wu, Rui [2 ]
Tiwari, Ram C. [1 ]
机构
[1] US FDA, Off Biostat, Silver Spring, MD 20993 USA
[2] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
关键词
Bayesian criterion; Bayesian paradigm; Beta-binomial; Noninferiority margin; Normal approximation; STATISTICAL-METHODS; PLACEBO; ISSUES;
D O I
10.1080/10543406.2011.589646
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Noninferiority trials are unique because they are dependent upon historical information in order to make meaningful interpretation of their results. Hence, a direct application of the Bayesian paradigm in sequential learning becomes apparently useful in the analysis. This paper describes a Bayesian procedure for testing noninferiority in two-arm studies with a binary primary endpoint that allows the incorporation of historical data on an active control via the use of informative priors. In particular, the posteriors of the response in historical trials are assumed as priors for its corresponding parameters in the current trial, where that treatment serves as the active control. The Bayesian procedure includes a fully Bayesian method and two normal approximation methods on the prior and/or on the posterior distributions. Then a common Bayesian decision criterion is used but with two prespecified cutoff levels, one for the approximation methods and the other for the fully Bayesian method, to determine whether the experimental treatment is noninferior to the active control. This criterion is evaluated and compared with the frequentist method using simulation studies in keeping with regulatory framework that new methods must protect type I error and arrive at a similar conclusion with existing standard strategies. Results show that both methods arrive at comparable conclusions of noninferiority when applied to a modified real data set. The advantage of the proposed Bayesian approach lies in its ability to provide posterior probabilities for effect sizes of the experimental treatment over the active control.
引用
收藏
页码:902 / 919
页数:18
相关论文
共 50 条
  • [21] A systematic review of noninferiority margins in oncology clinical trials
    Hashim, Mahmoud
    Vincken, Talitha
    Kroi, Florint
    Gebregergish, Samron
    Spencer, Mike
    Wang, Jianping
    Kampfenkel, Tobias
    Lam, Annette
    He, Jianming
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (06) : 443 - 455
  • [22] Challenges in the Design and Interpretation of Noninferiority Trials Insights From Recent Stent Trials
    Macaya, Fernando
    Ryan, Nicola
    Salinas, Pablo
    Pocock, Stuart J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (07) : 894 - 903
  • [23] BAYESIAN-ANALYSIS OF THE DIFFERENCE OF 2 PROPORTIONS
    PHAMGIA, T
    TURKKAN, N
    ENG, P
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1993, 22 (06) : 1755 - 1771
  • [24] Evidence-Based Medicine: The Design and Interpretation of Noninferiority Clinical Trials in Veterinary Medicine
    Freise, K. J.
    Lin, T. -L.
    Fan, T. M.
    Recta, V.
    Clark, T. P.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2013, 27 (06) : 1305 - 1317
  • [25] THE REPORTING QUALITY OF NONINFERIORITY TRIALS USING INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS
    Jia, Huixun
    Li, Tong
    Wan, Hongli
    Wu, Zhenyu
    Sun, Xiaodong
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (02): : 243 - 253
  • [26] A covariate-adjustment regression model approach to noninferiority margin definition
    Nie, Lei
    Soon, Guoxing
    STATISTICS IN MEDICINE, 2010, 29 (10) : 1107 - 1113
  • [27] Incorporating a companion test into the noninferiority design of medical device trials
    Lu, Nelson T.
    Xu, Yunling
    Yang, Ying
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (01) : 143 - 150
  • [28] Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia
    Alfred Sorbello
    Scott Komo
    Thamban Valappil
    Drug information journal : DIJ / Drug Information Association, 2010, 44 : 165 - 176
  • [29] Noninferiority Margin for Clinical Trials of Antibacterial Drugs for Nosocomial Pneumonia
    Sorbello, Alfred
    Komo, Scott
    Valappil, Thamban
    DRUG INFORMATION JOURNAL, 2010, 44 (02): : 165 - 176
  • [30] Mixed noninferiority margin and statistical tests in active controlled trials
    Tsou, Hsiao-Hui
    Hsiao, Chin-Fu
    Chow, Shein-Chung
    Yue, Lilly
    Xu, Yunling
    Lee, Shiowjen
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (02) : 339 - 357